Intrinsic value of Owens&Minor - OMI

Previous Close

$8.86

  Intrinsic Value

$110.09

stock screener

  Rating & Target

str. buy

+999%

Previous close

$8.86

 
Intrinsic value

$110.09

 
Up/down potential

+999%

 
Rating

str. buy

We calculate the intrinsic value of OMI stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  8.50
  8.15
  7.83
  7.55
  7.30
  7.07
  6.86
  6.67
  6.51
  6.36
  6.22
  6.10
  5.99
  5.89
  5.80
  5.72
  5.65
  5.58
  5.53
  5.47
  5.43
  5.38
  5.34
  5.31
  5.28
  5.25
  5.23
  5.20
  5.18
  5.16
Revenue, $m
  10,110
  10,934
  11,791
  12,681
  13,607
  14,568
  15,568
  16,607
  17,687
  18,811
  19,981
  21,200
  22,470
  23,793
  25,173
  26,613
  28,116
  29,686
  31,327
  33,041
  34,834
  36,709
  38,671
  40,724
  42,874
  45,126
  47,484
  49,955
  52,544
  55,258
Variable operating expenses, $m
  7,343
  7,934
  8,548
  9,187
  9,851
  10,541
  11,257
  12,003
  12,778
  13,584
  14,334
  15,208
  16,119
  17,068
  18,058
  19,091
  20,170
  21,296
  22,472
  23,702
  24,988
  26,333
  27,741
  29,214
  30,756
  32,371
  34,063
  35,836
  37,693
  39,640
Fixed operating expenses, $m
  2,563
  2,620
  2,677
  2,736
  2,796
  2,858
  2,921
  2,985
  3,051
  3,118
  3,186
  3,256
  3,328
  3,401
  3,476
  3,553
  3,631
  3,711
  3,792
  3,876
  3,961
  4,048
  4,137
  4,228
  4,321
  4,416
  4,513
  4,613
  4,714
  4,818
Total operating expenses, $m
  9,906
  10,554
  11,225
  11,923
  12,647
  13,399
  14,178
  14,988
  15,829
  16,702
  17,520
  18,464
  19,447
  20,469
  21,534
  22,644
  23,801
  25,007
  26,264
  27,578
  28,949
  30,381
  31,878
  33,442
  35,077
  36,787
  38,576
  40,449
  42,407
  44,458
Operating income, $m
  205
  381
  566
  758
  960
  1,170
  1,390
  1,619
  1,859
  2,109
  2,461
  2,736
  3,023
  3,324
  3,639
  3,969
  4,316
  4,680
  5,062
  5,463
  5,884
  6,327
  6,793
  7,282
  7,797
  8,338
  8,907
  9,507
  10,137
  10,800
EBITDA, $m
  334
  514
  701
  898
  1,103
  1,317
  1,540
  1,774
  2,018
  2,273
  2,539
  2,818
  3,111
  3,417
  3,737
  4,073
  4,426
  4,796
  5,184
  5,592
  6,021
  6,471
  6,944
  7,441
  7,964
  8,514
  9,093
  9,702
  10,342
  11,016
Interest expense (income), $m
  28
  49
  59
  71
  82
  95
  107
  120
  134
  148
  163
  178
  194
  211
  228
  247
  265
  285
  306
  327
  350
  373
  398
  423
  450
  478
  508
  538
  571
  604
  640
Earnings before tax, $m
  156
  322
  495
  676
  865
  1,063
  1,269
  1,485
  1,710
  1,946
  2,283
  2,541
  2,812
  3,095
  3,392
  3,704
  4,031
  4,374
  4,735
  5,113
  5,511
  5,930
  6,370
  6,832
  7,319
  7,831
  8,369
  8,936
  9,533
  10,160
Tax expense, $m
  42
  87
  134
  183
  234
  287
  343
  401
  462
  525
  616
  686
  759
  836
  916
  1,000
  1,088
  1,181
  1,278
  1,381
  1,488
  1,601
  1,720
  1,845
  1,976
  2,114
  2,260
  2,413
  2,574
  2,743
Net income, $m
  114
  235
  361
  493
  632
  776
  926
  1,084
  1,249
  1,421
  1,666
  1,855
  2,053
  2,259
  2,476
  2,704
  2,943
  3,193
  3,456
  3,733
  4,023
  4,329
  4,650
  4,987
  5,343
  5,716
  6,110
  6,523
  6,959
  7,417

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  3,663
  3,962
  4,272
  4,595
  4,930
  5,278
  5,640
  6,017
  6,408
  6,816
  7,240
  7,681
  8,141
  8,621
  9,121
  9,642
  10,187
  10,756
  11,350
  11,971
  12,621
  13,300
  14,011
  14,755
  15,534
  16,350
  17,204
  18,100
  19,038
  20,021
Adjusted assets (=assets-cash), $m
  3,663
  3,962
  4,272
  4,595
  4,930
  5,278
  5,640
  6,017
  6,408
  6,816
  7,240
  7,681
  8,141
  8,621
  9,121
  9,642
  10,187
  10,756
  11,350
  11,971
  12,621
  13,300
  14,011
  14,755
  15,534
  16,350
  17,204
  18,100
  19,038
  20,021
Revenue / Adjusted assets
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
  2.760
Average production assets, $m
  597
  645
  696
  748
  803
  860
  918
  980
  1,044
  1,110
  1,179
  1,251
  1,326
  1,404
  1,485
  1,570
  1,659
  1,751
  1,848
  1,949
  2,055
  2,166
  2,282
  2,403
  2,530
  2,662
  2,802
  2,947
  3,100
  3,260
Working capital, $m
  829
  897
  967
  1,040
  1,116
  1,195
  1,277
  1,362
  1,450
  1,543
  1,638
  1,738
  1,843
  1,951
  2,064
  2,182
  2,306
  2,434
  2,569
  2,709
  2,856
  3,010
  3,171
  3,339
  3,516
  3,700
  3,894
  4,096
  4,309
  4,531
Total debt, $m
  1,100
  1,309
  1,526
  1,752
  1,986
  2,229
  2,483
  2,746
  3,019
  3,304
  3,600
  3,909
  4,231
  4,566
  4,915
  5,280
  5,661
  6,058
  6,474
  6,908
  7,362
  7,837
  8,334
  8,854
  9,398
  9,968
  10,566
  11,192
  11,847
  12,535
Total liabilities, $m
  2,561
  2,769
  2,986
  3,212
  3,446
  3,690
  3,943
  4,206
  4,479
  4,764
  5,061
  5,369
  5,691
  6,026
  6,375
  6,740
  7,121
  7,518
  7,934
  8,368
  8,822
  9,297
  9,794
  10,314
  10,858
  11,429
  12,026
  12,652
  13,307
  13,995
Total equity, $m
  1,103
  1,192
  1,286
  1,383
  1,484
  1,589
  1,698
  1,811
  1,929
  2,052
  2,179
  2,312
  2,450
  2,595
  2,745
  2,902
  3,066
  3,238
  3,416
  3,603
  3,799
  4,003
  4,217
  4,441
  4,676
  4,921
  5,179
  5,448
  5,730
  6,026
Total liabilities and equity, $m
  3,664
  3,961
  4,272
  4,595
  4,930
  5,279
  5,641
  6,017
  6,408
  6,816
  7,240
  7,681
  8,141
  8,621
  9,120
  9,642
  10,187
  10,756
  11,350
  11,971
  12,621
  13,300
  14,011
  14,755
  15,534
  16,350
  17,205
  18,100
  19,037
  20,021
Debt-to-equity ratio
  1.000
  1.100
  1.190
  1.270
  1.340
  1.400
  1.460
  1.520
  1.570
  1.610
  1.650
  1.690
  1.730
  1.760
  1.790
  1.820
  1.850
  1.870
  1.890
  1.920
  1.940
  1.960
  1.980
  1.990
  2.010
  2.030
  2.040
  2.050
  2.070
  2.080
Adjusted equity ratio
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301
  0.301

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  114
  235
  361
  493
  632
  776
  926
  1,084
  1,249
  1,421
  1,666
  1,855
  2,053
  2,259
  2,476
  2,704
  2,943
  3,193
  3,456
  3,733
  4,023
  4,329
  4,650
  4,987
  5,343
  5,716
  6,110
  6,523
  6,959
  7,417
Depreciation, amort., depletion, $m
  129
  133
  136
  139
  143
  147
  151
  155
  159
  163
  78
  83
  88
  93
  98
  104
  110
  116
  122
  129
  136
  143
  151
  159
  168
  176
  186
  195
  205
  216
Funds from operations, $m
  243
  367
  497
  633
  775
  923
  1,077
  1,239
  1,408
  1,584
  1,745
  1,938
  2,140
  2,352
  2,575
  2,808
  3,052
  3,309
  3,579
  3,862
  4,159
  4,472
  4,801
  5,147
  5,510
  5,893
  6,295
  6,718
  7,164
  7,633
Change in working capital, $m
  65
  68
  70
  73
  76
  79
  82
  85
  89
  92
  96
  100
  104
  109
  113
  118
  123
  129
  135
  141
  147
  154
  161
  168
  176
  185
  193
  203
  212
  223
Cash from operations, $m
  178
  300
  427
  560
  699
  844
  995
  1,153
  1,319
  1,492
  1,649
  1,838
  2,036
  2,244
  2,462
  2,690
  2,929
  3,180
  3,444
  3,721
  4,012
  4,318
  4,640
  4,978
  5,334
  5,708
  6,102
  6,516
  6,952
  7,411
Maintenance CAPEX, $m
  -36
  -40
  -43
  -46
  -50
  -53
  -57
  -61
  -65
  -69
  -74
  -78
  -83
  -88
  -93
  -98
  -104
  -110
  -116
  -122
  -129
  -136
  -143
  -151
  -159
  -168
  -176
  -186
  -195
  -205
New CAPEX, $m
  -48
  -49
  -51
  -53
  -55
  -57
  -59
  -61
  -64
  -66
  -69
  -72
  -75
  -78
  -81
  -85
  -89
  -93
  -97
  -101
  -106
  -111
  -116
  -121
  -127
  -133
  -139
  -146
  -153
  -160
Cash from investing activities, $m
  -84
  -89
  -94
  -99
  -105
  -110
  -116
  -122
  -129
  -135
  -143
  -150
  -158
  -166
  -174
  -183
  -193
  -203
  -213
  -223
  -235
  -247
  -259
  -272
  -286
  -301
  -315
  -332
  -348
  -365
Free cash flow, $m
  93
  212
  334
  461
  594
  734
  879
  1,031
  1,190
  1,356
  1,506
  1,688
  1,878
  2,078
  2,287
  2,506
  2,737
  2,978
  3,232
  3,498
  3,778
  4,072
  4,381
  4,706
  5,048
  5,408
  5,786
  6,185
  6,604
  7,045
Issuance/(repayment) of debt, $m
  200
  209
  217
  226
  234
  244
  253
  263
  274
  285
  296
  309
  322
  335
  350
  365
  381
  398
  415
  434
  454
  475
  497
  520
  544
  570
  597
  626
  656
  687
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  200
  209
  217
  226
  234
  244
  253
  263
  274
  285
  296
  309
  322
  335
  350
  365
  381
  398
  415
  434
  454
  475
  497
  520
  544
  570
  597
  626
  656
  687
Total cash flow (excl. dividends), $m
  293
  420
  551
  687
  829
  977
  1,132
  1,294
  1,464
  1,641
  1,802
  1,997
  2,200
  2,413
  2,637
  2,871
  3,117
  3,376
  3,647
  3,932
  4,232
  4,547
  4,878
  5,226
  5,592
  5,978
  6,383
  6,810
  7,260
  7,732
Retained Cash Flow (-), $m
  -87
  -90
  -93
  -97
  -101
  -105
  -109
  -113
  -118
  -123
  -128
  -133
  -138
  -144
  -151
  -157
  -164
  -171
  -179
  -187
  -196
  -204
  -214
  -224
  -234
  -246
  -257
  -269
  -282
  -296
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  206
  330
  457
  590
  728
  872
  1,023
  1,181
  1,346
  1,519
  1,675
  1,864
  2,062
  2,269
  2,486
  2,714
  2,953
  3,204
  3,468
  3,745
  4,036
  4,342
  4,664
  5,002
  5,358
  5,732
  6,126
  6,541
  6,977
  7,436
Discount rate, %
  8.10
  8.51
  8.93
  9.38
  9.85
  10.34
  10.85
  11.40
  11.97
  12.57
  13.19
  13.85
  14.55
  15.27
  16.04
  16.84
  17.68
  18.57
  19.49
  20.47
  21.49
  22.57
  23.69
  24.88
  26.12
  27.43
  28.80
  30.24
  31.75
  33.34
PV of cash for distribution, $m
  191
  281
  354
  412
  455
  483
  497
  498
  487
  465
  428
  393
  353
  310
  267
  225
  185
  149
  118
  90
  68
  49
  35
  24
  16
  11
  7
  4
  2
  1
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Owens & Minor, Inc. is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company's segments include Domestic, International and Clinical & Procedural Solutions (CPS). The Domestic Segment offers a portfolio of products and services to healthcare providers and manufacturers in the United States. The Company also offers additional services to healthcare providers, including supplier management, analytics, inventory management, outsourced resource management, clinical supply management and business process consulting. The International segment includes its European distribution and logistics business. The CPS segment provides product-related solutions, helping manufacturers and healthcare providers source, assemble and deliver procedure kits to the point-of-care.

FINANCIAL RATIOS  of  Owens&Minor (OMI)

Valuation Ratios
P/E Ratio 5
Price to Sales 0.1
Price to Book 0.6
Price to Tangible Book
Price to Cash Flow 2.9
Price to Free Cash Flow 3.4
Growth Rates
Sales Growth Rate -0.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -18.9%
Cap. Spend. - 3 Yr. Gr. Rate -12.9%
Financial Strength
Quick Ratio NaN
Current Ratio 0.2
LT Debt to Equity 58.9%
Total Debt to Equity 58.9%
Interest Coverage 7
Management Effectiveness
Return On Assets 4.6%
Ret/ On Assets - 3 Yr. Avg. 4%
Return On Total Capital 7.1%
Ret/ On T. Cap. - 3 Yr. Avg. 6.1%
Return On Equity 11.2%
Return On Equity - 3 Yr. Avg. 9.4%
Asset Turnover 3.5
Profitability Ratios
Gross Margin 12.2%
Gross Margin - 3 Yr. Avg. 12.3%
EBITDA Margin 2.6%
EBITDA Margin - 3 Yr. Avg. 2.5%
Operating Margin 2%
Oper. Margin - 3 Yr. Avg. 1.9%
Pre-Tax Margin 1.8%
Pre-Tax Margin - 3 Yr. Avg. 1.6%
Net Profit Margin 1.1%
Net Profit Margin - 3 Yr. Avg. 1%
Effective Tax Rate 37%
Eff/ Tax Rate - 3 Yr. Avg. 41.4%
Payout Ratio 57.8%

OMI stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the OMI stock intrinsic value calculation we used $9318.275 million for the last fiscal year's total revenue generated by Owens&Minor. The default revenue input number comes from 0001 income statement of Owens&Minor. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our OMI stock valuation model: a) initial revenue growth rate of 8.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.1%, whose default value for OMI is calculated based on our internal credit rating of Owens&Minor, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Owens&Minor.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of OMI stock the variable cost ratio is equal to 72.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $2508 million in the base year in the intrinsic value calculation for OMI stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Owens&Minor.

Corporate tax rate of 27% is the nominal tax rate for Owens&Minor. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the OMI stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for OMI are equal to 5.9%.

Life of production assets of 15.1 years is the average useful life of capital assets used in Owens&Minor operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for OMI is equal to 8.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1015.479 million for Owens&Minor - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 62.318 million for Owens&Minor is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Owens&Minor at the current share price and the inputted number of shares is $0.6 billion.

RELATED COMPANIES Price Int.Val. Rating
HSIC Henry Schein 86.04 88.84  hold
CAH Cardinal Healt 57.63 162.77  str.buy
DYNT Dynatronics 2.71 0.16  str.sell
PINC Premier 39.86 84.69  str.buy
JNJ Johnson&Johnso 144.50 176.79  buy
TFX Teleflex 260.66 204.28  hold

COMPANY NEWS

▶ Why Owens & Minor Inc (NYSE:OMI) Could Be Worth Watching   [Nov-02-18 12:20PM  Simply Wall St.]
▶ Owens & Minor (OMI) Meets Q3 Earnings Estimates   [Oct-31-18 07:55AM  Zacks]
▶ Owens & Minor: 3Q Earnings Snapshot   [06:51AM  Associated Press]
▶ Why Owens & Minor's Shares Crashed 17.5% Today   [Aug-07-18 04:47PM  Motley Fool]
▶ Owens & Minor: 2Q Earnings Snapshot   [07:03AM  Associated Press]
▶ Best Dividend Stocks This Month   [Jun-27-18 09:02AM  Simply Wall St.]
▶ June Undervalued Utilities Opportunities   [Jun-09-18 08:02AM  Simply Wall St.]
▶ Best-In-Class Dividend Stocks   [May-27-18 09:02AM  Simply Wall St.]
▶ Top 3 Undervalued Stocks For The Month   [May-22-18 10:02AM  Simply Wall St.]
▶ May Healthcare Dividend Stocks To Look Out For   [May-11-18 06:02AM  Simply Wall St.]
▶ May Top Undervalued Utilities Stocks To Look Out For   [May-09-18 08:02AM  Simply Wall St.]
▶ Top Cheap Stocks This Week   [Apr-20-18 10:02AM  Simply Wall St.]
▶ Flavor Of The Month: Arotech And More   [Mar-16-18 10:02AM  Simply Wall St.]
▶ March Undervalued Utilities Stock Opportunities   [07:02AM  Simply Wall St.]
▶ New Strong Sell Stocks for March 7th   [Mar-07-18 07:39AM  Zacks]
▶ Owens & Minor tops Street 4Q forecasts   [Feb-14-18 10:33AM  Associated Press]
▶ [$$] Amazon Hospital-Supply Push Marks Its Latest Move Into Health Care   [Feb-13-18 07:06PM  The Wall Street Journal]
▶ Top NasdaqGS Healthcare Dividend Paying Companies   [Feb-09-18 05:02AM  Simply Wall St.]
▶ PayPal and UPS stumble while eBay and Qorvo advance   [Feb-01-18 04:38PM  Associated Press]
▶ Owens & Minor Previews 2017 Preliminary Financial Results   [Jan-31-18 05:51PM  Business Wire]
▶ December Dividend Stocks To Look Out For   [Dec-10-17 08:02AM  Simply Wall St.]
▶ Healthcare Dividend Stocks Investors Love   [Nov-17-17 05:02AM  Simply Wall St.]
▶ Best Cheap Stocks To Buy   [09:02AM  Simply Wall St.]
▶ Owens & Minor misses Street 3Q forecasts   [07:12AM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.